JMP Securities downgraded Insmed (NASDAQ: INSM) from Market Outperform to Market Perform.Analyst Liisa Bayko comments "After consulting with a regulatory ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE